Guardant Health Q3 EPS $(0.14) Beats $(0.37) Estimate, Sales $60.8M Beat $45.42M Estimate

Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.37) by 62.16 percent. This is a 92.78 percent increase over losses of $(1.94) per share from the

Benzinga · 11/07/2019 21:39

Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.37) by 62.16 percent. This is a 92.78 percent increase over losses of $(1.94) per share from the same period last year. The company reported quarterly sales of $60.8 million which beat the analyst consensus estimate of $45.42 million by 33.86 percent. This is a 180.29 percent increase over sales of $21.692 million the same period last year.